| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Smita Sarma | |
| Shalini Upadhyay | |||
| P2860 | cites work | Biofilms of non-Candida albicans Candidaspecies: quantification, structure and matrix composition | Q60483680 |
| Risk factors for hospital-acquired candidemia. A matched case-control study | Q69771679 | ||
| Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia | Q28818814 | ||
| Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts | Q30561825 | ||
| Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. | Q30834974 | ||
| Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
| Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. | Q33609053 | ||
| Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. | Q34042232 | ||
| First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
| Epidemiology of Candida species infections in critically ill non-immunosuppressed patients | Q34273626 | ||
| New clonal strain of Candida auris, Delhi, India | Q34372060 | ||
| Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India | Q34485537 | ||
| Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America | Q34505582 | ||
| First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
| Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage | Q35112435 | ||
| Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek | Q35586995 | ||
| Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection | Q35941512 | ||
| Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry | Q36049838 | ||
| Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr | Q37036246 | ||
| A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece | Q37115815 | ||
| Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
| Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016. | Q39092367 | ||
| Candida auris-associated candidemia, South Africa | Q42712931 | ||
| Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
| Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
| Candidemia caused by amphotericin B and fluconazole resistant Candida auris | Q44304263 | ||
| Recent advances in the study of antifungal lead compounds with new chemical scaffolds | Q46733227 | ||
| Emergence of Candida auris: An International Call to Arms | Q48721573 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| Candida auris | Q26816853 | ||
| P304 | page(s) | 155-165 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Infection and Drug Resistance | Q15716352 |
| P1476 | title | Current perspective on emergence, diagnosis and drug resistance in Candida auris | |
| P478 | volume | 10 |
| Q104459233 | Active neutrophil responses counteract Candida albicans burn wound infection of ex vivo human skin explants |
| Q64110181 | Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of , , , and spp |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q48220845 | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen |
| Q49988058 | Candida auris: a Review of the Literature. |
| Q90610965 | Clade II Candida auris possess genomic structural variations related to an ancestral strain |
| Q50128552 | Containment strategies to address the expanding threat of multidrug-resistant Candida auris |
| Q42359201 | Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier |
| Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
| Q49679927 | Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All. |
| Q47195606 | In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris |
| Q92039317 | In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris |
| Q64242716 | Investigating Antifungal Susceptibility in Species With MALDI-TOF MS-Based Assays |
| Q55032754 | Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives. |
| Q92666321 | Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen |
| Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
| Q90460596 | Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box |
| Q64276428 | Risk factors for Candida urinary tract infections in dogs and cats |
| Q64962326 | Strengthening the One Health Agenda: The Role of Molecular Epidemiology in Aspergillus Threat Management. |
Search more.